NeuroLux
Private Company
Funding information not available
Overview
NeuroLux is a private, commercial-stage company providing cutting-edge, customizable tools for wireless optogenetics and physiological monitoring in preclinical rodent research. Its core technology platform centers on ultra-lightweight, flexible, and fully-implantable devices that receive power and control wirelessly, eliminating the need for tethers, external batteries, or head-mounted hardware. The company offers a complete system, including a power distribution control box, autotuner, and software, and serves neuroscience laboratories worldwide. NeuroLux's solutions enable more naturalistic behavioral studies and multimodal data collection, positioning it as a key enabler in the expanding field of systems neuroscience and neuromodulation research.
Technology Platform
A platform for fully-implantable, wireless, and battery-free devices for optogenetic neuromodulation and physiological monitoring in small animals. It consists of a wireless power delivery system (PDC Box & Autotuner), ultra-lightweight flexible implants with µLEDs or sensors, and control/analysis software.
Opportunities
Risk Factors
Competitive Landscape
NeuroLux competes in the niche of wireless optogenetics tools. Direct competitors may include other startups (e.g., Kendall Research, now part of Inscopix). It faces indirect competition from traditional tethered fiber optic system providers and larger companies in the preclinical telemetry space (e.g., Data Sciences International, Starr Life Sciences). Its competitive edge is its fully implantable, battery-free, and ultra-lightweight design.